CClinicalTrials.gg
CompletedNCT04401501Updated Apr 27, 2021

Effects of Manual Therapy on the Upper Cervical Spine Combined With Exercise vs Isolated Exercise in Patients With Cervicogenic Headache.

An interventional study of Manual Therapy and Exercises and Exercise in Cervicogenic Headache and Headache, sponsored by Universidad de Zaragoza. Completed at 1 site in Spain. Open to participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2021-04-27.

Sponsored by Universidad de Zaragoza · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years to 90 Years
Sex
All
01

Study summary

Cervicogenic headache is defined as unilateral headache associated with neck pain. Effect of manual translatoric therapy of the upper cervical spine associated with cervical exercises in these patients is currently unknown. Our aim was to determine if adding manual therapy to an exercise and home-exercise program improved effects on symptoms and function in short- and mid-term in patients with cervicogenic headache.

A randomized controlled study will be conducted with 40 subjects with cervicogenic headache. Each group will receive four 20-minute sessions weekly and a home-exercise program. Upper cervical flexion, flexion-rotation test, Impact Headache Test-6 (HIT-6), headache intensity, craniocervical flexion test, pain pressure thresholds and Global Rating of Change (GROC)-Scale will be assessed at end of the intervention, at 3- and at 6-month follow-ups.

02

Conditions studied

  • Cervicogenic Headache
  • Headache

Keywords

  • Cervicogenic headache
  • exercise
  • manual therapy
  • upper cervical spine
03

In context

Post-Traumatic Headache

188 studies on the registry are indexed under Post-Traumatic Headache; 51 are open to participants now.

This study's enrollment of 40 is close to the median of 44 across 166 interventional studies indexed under Post-Traumatic Headache.

Browse Post-Traumatic Headache studies →

Lead sponsor

Universidad de Zaragoza is the lead sponsor of 109 studies on the registry; 19 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Diagnosis of cervicogenic headache according to Sjaastad et al. Subjects will have to fulfill both parts I and III of the major criteria for diagnosis (pain aggravated by neck movement, sustained position or external pressure, restricted cervical range of motion, and unilateral pain starting in the neck and radiating to the frontotemporal region)
  • Hypomobility in one or more segments of C0-1, C1-2, C2-3 through manual evaluation.
  • A positive result in the flexion-rotation test.
  • A failure to pass stage 2 (24 mmHg) of the craniocervical flexion test.
  • Be at least 18 years old.
  • Have signed the informed consent.

Exclusion criteria

Exclusion Criteria:

  • Contraindications for manual therapy or exercise.
  • Participation in exercise or manual therapy programs in the last three months.
  • Inability to maintain supine position.
  • The use of pacemakers (the magnets in the CROM device could alter their signal).
  • Inability to perform the flexion-rotation test.
  • Language difficulties.
  • Pending litigation or lawsuits.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
40 participants (actual)

Study arms

  • Experimental
    Manual Therapy + Exercise Group

    Combination of manual therapy and exercises for cervicogenic headache

    Other: Manual Therapy and Exercises

  • Active comparator
    Exercise Group

    Only exercises for cervicogenic headache

    Other: Exercise

Interventions

  • OtherManual Therapy and Exercises

    Combination of physiotherapy (manual therapy) techniques and exercises for cervicogenic headache

  • OtherExercise

    Exercises for cervicogenic headache

06

What researchers measure

Primary outcomes

  1. Headache Intensity (HIT-6)

    Test-6 questionnaire (HIT-6) will be used to describe the degree of pain and disability caused by the headache, with a reliability higher than 0.70. The results are classified into four categories that score daily life impact of headache (little or none, some, substantial and severe.

    Time frame: Change between baseline and post intervention (1 month), after 3 months and after 6 months

  2. Flexion-rotation test

    This test is used to see the amount of movement of the upper cervical spine and is the test most used in the literature. It is positive when there is a decrease of 10 degrees or more in the cervical rotation with maximum flexion, in a sense with respect to the contralateral or presents hypomobility of segment C1 with a mobility less than 32º

    Time frame: Change between baseline and post intervention (1 month), after 3 months and after 6 months

Secondary outcomes

  1. Upper cervical flexion range of motion

    Active flexion of the upper cervical spine will be measured in standing position using a CROM device

    Time frame: Change between baseline and post intervention (1 month), after 3 months and after 6 months

  2. Headache Intensity

    Headache intensity will be assessed on a visual analogue scale from 0 to 10 cm.

    Time frame: Change between baseline and post intervention (1 month), after 3 months and after 6 months

  3. Craniocervical flexion test

    This test will be used to measure the strength of the deep flexor muscles. The activation and resistance of the deep flexor muscles will be evaluated in five progressive pressure increases of 2 mmHg up to a maximum of 30 mmHg. The patient will pass to the next level after reaching one certain level three times.

    Time frame: Change between baseline and post intervention (1 month), after 3 months and after 6 months

  4. Pain Pressure Thresholds

    Pain pressure thresholds will be measured using a digital algometer (Somedic AB Farsta, Somedic SenseLab AB, Sweden) with a round surface area of 1 cm2. Pressure will be applied at a rate of 1 kg/cm2/s, perpendicular to the skin. Pressure pain thresholds will be assessed over six points bilaterally with the subject in supine position: suboccipital region, C2-3, C5-6, elevator of scapula, trapezius and first metacarpal joint.

    Time frame: Change between baseline and post intervention (1 month), after 3 months and after 6 months

  5. Global Raiting of Scale (GROC-Scale)

    GROC-Scale will be used to measure the personal evolution that the patient had experienced. This scale is considered to be an efficient way to score patients' perceived clinical change and test-reliability has shown to be excellent (ICC=0.90).

    Time frame: Change between baseline and post intervention (1 month), after 3 months and after 6 months

  6. Adherence to self-treatment scale

    This scale will be used in order to measure the adherence to self-treatment at home. Patients will be asked to choose between the following answers: "I have done the exercises every day"; "I have performed the exercises 4-6 days a week"; "I have performed the exercises 1-3 days a week"; "I have performed the exercises less than 1 day a week"; or "I have not performed them".

    Time frame: Change between baseline and post intervention (1 month), after 3 months and after 6 months

07

Study locations

1 site
  • Universidad de Zaragoza
    Zaragoza, 50009, Spain
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 27, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04401501
Lead sponsor
Universidad de Zaragoza
Responsible party
Jacobo Rodríguez-Sanz (Principal Investigator, Universidad de Zaragoza) — Principal investigator
First posted
May 26, 2020
Start date
Jun 1, 2020
Primary completion
Dec 1, 2020
Completion
Jan 1, 2021
Last update
Apr 27, 2021

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion